Showing results (201-210 of 3,189) with videos related to
Sort By:
Pageof 319
JAMA|April 23, 1982
Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infectionC I Smith, L W Kitchen, G H Scullard, et al.Journal of Acquired Immune Deficiency Syndromes|August 1, 1994
HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patientsM J Kozal, R W Shafer, M A Winters, et al.Annals of Internal Medicine|August 15, 1994
Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapyM J Kozal, K Kroodsma, M A Winters, et al.Journal of Virology|October 24, 2000
Genotypic, phenotypic, and modeling studies of a deletion in the beta3-beta4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitorsM A Winters, K L Coolley, P Cheng, et al.Antimicrobial Agents and Chemotherapy|August 1, 1989
Pharmacokinetics of rifabutinM H Skinner, M Hsieh, J Torseth, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985
Treatment of nasopharyngeal carcinoma with human leukocyte interferonJ M Connors, W A Andiman, C B Howarth, et al.Journal of Virology|February 1, 1996
Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapyA K Iversen, R W Shafer, K Wehrly, et al.Annals of Neurology|July 1, 1984
Human leukocyte interferon administration to patients with symptomatic and suspected rabiesT C Merigan, G M Baer, W G Winkler, et al.Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Plasma viremia in human immunodeficiency virus infection: relationship to stage of disease and antiviral treatmentD A Katzenstein, M Holodniy, D M Israelski, et al.The Journal of Infectious Diseases|May 6, 1999
Clinical resistance patterns and responses to two sequential protease inhibitor regimens in saquinavir and reverse transcriptase inhibitor-experienced personsJ Lawrence, J Schapiro, M Winters, et al.Pageof 319